Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other financing activities: 2020-2022

Historic Other financing activities for Prime Medicine (PRME) over the last 3 years, with Dec 2022 value amounting to $4.0 million.

  • Prime Medicine's Other financing activities rose 28.91% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2022, which is 272.19% up from last year.
  • Latest data reveals that Prime Medicine reported Other financing activities of $4.0 million as of FY2022, which was up 272.19% from $1.1 million recorded in FY2021.
  • In the past 5 years, Prime Medicine's Other financing activities registered a high of $4.0 million during FY2022, and its lowest value of $20,000 during FY2020.
  • For the 3-year period, Prime Medicine's Other financing activities averaged around $1.7 million, with its median value being $1.1 million (2021).
  • Data for Prime Medicine's Other financing activities shows a peak YoY spiked of 5,330.00% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Prime Medicine's Other financing activities stood at $20,000 in 2020, then surged by 5,330.00% to $1.1 million in 2021, then spiked by 272.19% to $4.0 million in 2022.